P
Park Dental Partners Inc
NASDAQ:PARK
Park Dental Partners Inc
NASDAQ:PARK
Price:
18.12
USD
-2.58%
Market Closed
Market Cap:
$74.1m
Relative Value
There is not enough data to reliably calculate the relative value of PARK.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
PARK
Relative Value
Base Case
Not Available
Multiples Across Competitors
PARK Competitors Multiples
Park Dental Partners Inc Competitors
Park Dental Partners Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
P
|
Park Dental Partners Inc
NASDAQ:PARK
|
77m USD | 0 | 0 | 0 | 0 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
97B USD | 0.2 | 54.9 | 14 | 14 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
68.2B EUR | 0.3 | 13.3 | 7.8 | 9.9 | |
| US |
|
Cigna Corp
NYSE:CI
|
69.1B USD | 0.3 | 11.6 | 0 | 0 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
27.3B EUR | 1.2 | 21.6 | 10 | 14.9 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
22.9B EUR | 1.2 | 23.4 | 9 | 16.7 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
22.1B USD | 1.6 | 25.2 | 12.1 | 17.6 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
22.1B USD | 2 | 22.4 | 12.4 | 16.8 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.1B EUR | 0.6 | 11.3 | 5.4 | 10 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.8B USD | 12 | -28.4 | -30.5 | -27.7 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.4B USD | 0.8 | 13.9 | 7.3 | 9.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
